Investigating the effect of nutritional supplements in heart failure

Investigating the effectiveness of L-carnitine on heart failure patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20240624062239N1

Enrollment

100

Registered

2024-07-19

Start date

2024-12-21

Completion date

Unknown

Last updated

2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Heart failure. Heart failure

Interventions

Intervention 1: Intervention group: 250 mg L-carnitine daily for two months. Intervention 2: Control group: Placebo daily for two months.

Eligibility

Sex/Gender

All

Age

18 Years to 70 Years

Inclusion criteria

Inclusion criteria: Having heart failure and Ejection Fraction(EF) below 40

Exclusion criteria

Exclusion criteria: Having inflammatory, infectious, autoimmune and malignant , kidney, liver or thyroid diseases

Design outcomes

Primary

Measure	Time frame
Brief fatigue inventory(BFI) questionnaire fatigue score. Timepoint: Before the start of the intervention and 2 months after the start of L-carnitine supplementation or placebo. Method of measurement: Brief fatigue inventory (BFI).	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSepideh Jafari Naeini

Shahid Beheshti University of Medical Sciences

sdnaeini@yahoo.com+98 21 2207 4089

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026